Advisory Services Network, LLC Immunovant, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $75,499 - $95,996	-10,300 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$7.01 - $11.37 $9,113 - $14,780	1,300 Added 14.44%	10,300 $90,000
Q2 2021 Aug 12, 2021	BUY	$9.4 - $16.85 $84,600 - $151,650	9,000 New	9,000 $95,000
Q1 2021 May 24, 2021	SELL	$13.08 - $49.6 $9,156 - $34,720	-700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $15,827 - $27,230	700 New	700 $25,000

220

65.1M

697K

629K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.